Unfortunately, the noble aims of the Melbourne Consensus statement on the early detection of prostate cancer lack rigour, failing to take into account the breadth of evidence in this field; as a result, they fall disappointingly short of providing clarity on this important issue.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Change history
10 April 2014
In the version of this article initially published online, the first reference was incorrect. The error has been corrected for the print, HTML and PDF versions of the article.
References
Murphy, D. G. et al. The Melbourne Consensus Statement on the Early Detection of Prostate Cancer. BJU Int. http://dx.doi.org/10.1111/bju.12556.
Schroder, F. H. et al. Prostate-cancer mortality at 11 years of follow-up. N. Engl. J. Med. 366, 981–990 (2012).
Ilic, D., Neuberger, M. M., Djulbegovic, M. & Dahm, P. Screening for prostate cancer. Cochrane Database of Systematic Reviews. Issue 1. Art. No.: CD004720. doi:10.1002/14651858.CD004720.pub3 (2013).
Hugosson, J. et al. Mortality results from the Göteborg randomised population-based prostate-cancer screening trial. Lancet Oncol. 11, 725–732 (2010).
Cooperberg, M. R., Lubeck, D. P., Meng, M. V., Mehta, S. S. & Carroll, P. R. The changing face of low-risk prostate cancer: trends in clinical presentation and primary management. J. Clin. Oncol. 22, 2141–2149 (2004).
Ganz, P. A. et al. National Institutes of Health State-of-the-Science Conference: role of active surveillance in the management of men with localized prostate cancer. Ann. Intern. Med. 156, 591–595 (2012).
Mullins, J. K. et al. Multiparametric magnetic resonance imaging findings in men with low-risk prostate cancer followed using active surveillance. BJU Int. 111, 1037–1045 (2013).
Ahmed, H. U., Arya, M., Freeman, A. & Emberton, M. Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy? Lancet Oncol. 13, e509–e517 (2012).
Wilt, T. J. et al. Radical prostatectomy versus observation for localized prostate cancer. N. Engl. J. Med. 367, 203–213 (2012).
Resnick, M. J. et al. Long-term functional outcomes after treatment for localized prostate cancer. N. Engl. J. Med. 368, 436–445 (2013).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author receives funding from Sonacare, GlaxoSmithKline, Angiodynamics Inc., and Advanced Medical Diagnostics for clinical trials. He has previously received consultancy payments from Oncura/GE Healthcare and Steba Biotech but has no current medical consultancies.
Rights and permissions
About this article
Cite this article
Ahmed, H. Melbourne Consensus—noble but misguided. Nat Rev Urol 11, 250–251 (2014). https://doi.org/10.1038/nrurol.2014.65
Published:
Issue date:
DOI: https://doi.org/10.1038/nrurol.2014.65
This article is cited by
-
Prostate cancer: active surveillance may prove organisationally impossible
Irish Journal of Medical Science (1971 -) (2015)
